Canaan Partners IX LLC, Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 48,427 shares at $10.08 ($487K) on 2016-06-08, disclosed to the SEC on 2016-06-10.
Open-market sale of $487k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.08 | 22,885 | $231K | 47.3% |
| 2 | $10.06 | 22,842 | $230K | 47.1% |
| 3 | $10.01 | 2,700 | $27K | 5.5% |
| Total | $10.07 avg | 48,427 | $487K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-21 | $526K | — | Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-10 | $303K | — | Filing → |